135080-35-2

Upstream product

• 6195-45-5 meso-1,3,4,5,6-penta-O-benzyl-myo-inositol 
• 135080-36-3 1,3,4,5,6-penta-O-benzyl-myo-inositol triflate 
• 135080-37-4 1,2,3,4,5-penta-O-benzyl-scyllo-inositol trifluoroacetate 
• 100-39-0 benzyl bromide 
• 26276-99-3 rac-1,4,5,6-tetra-O-benzyl-myo-inositol 
• 22144-57-6 meso-2,3,4,5,6-O-pentabenzyl-scyllo-ionose 
• 22132-86-1 meso-2,3,4,5,6-O-pentabenzyl-scyllo-inositol 
• 28140-40-1 1,4,5,6-tetra-O-benzyl-myo-inositol 
• 100-44-7 benzyl chloride 
• 57029-87-5 (±)-1,2-cyclohexylidene myo-inositol 
• 87-89-8 D-myo-inositol 
• 38078-09-0 diethylamino-sulfur trifluoride 

Downstream Products

• 135212-48-5 2-deoxy-2-fluoro-myo-inositol 
• 85716-59-2 2-deoxy-2-fluoro-scyllo-inositol 

Relevant academic research and scientific papers

ACETYLATED PRODRUGS FOR DELIVERY ACROSS THE BLOOD-BRAIN BARRIER

The present disclosure relates to pharmaceutical compositions including a compound derived from a parent compound having a hydroxyl or amino moiety, wherein the hydroxyl in the parent compound is presented as an ester in the compound or the amino in the parent compound is presented as an amide in the compound, and their use to prevent or treat neurological disease.

Synthesis and Tritium Radiolabelling of Fluorinated Analogues of myo-Inositol

Syntheses have been developed for a set of six myo-inositol analogues from myo-inositol in which single hydroxy groups have been replaced by fluorine (monodeoxy-fluoro-myo-inositols).Except for 2-deoxy-2-fluoro-myo-inositol 32 and 1D-4-deoxy-4-fluoro-myo-

Synthesis of -Labelled and Unlabelled 2-Deoxy-2-fluoro-myo-inositol and 1-Deoxy-1-fluoro-scyllo-inositol for Use in Studies of the Phosphoinositide Cycle

2-Deoxy-2-fluoro-myo-inositol and 1-deoxy-1-fluoro-scyllo-inositol have been synthesized in their unlabelled and tritiated forms in order to study their potential as inhibitors of the phosphoinositide cycle.